1PM7

rmlc (dtdp-6-deoxy-d-xylo-4-hexulose 3,5-epimerase)structure from mycobacterium tuberculosis and inhibitor design. the apo structure.

• Total interactions analyzed: 1
• Total true interactions: 1
• Strongest Interaction:
  • Chains: A-B
  • Int. Res.: 138
  • Norm. En. per Res.: -4.1497
• Hub Node: A(1)

All Interactions

Chains	Hydro. Bond Ener. (kJ/mol)	Elec. Ener. (kJ/mol)	VDW. Ener. (kJ/mol)	Tot. Stab. Ener. (kJ/mol)	#int. res.	# Short cont.	#Hydr. int.	#VDW pairs	#salt bridges	#Pot. fav. elec. int	#Pot. unfav. elec. int
A-B	-188.541	21.9262	-406.041	-572.6558	138	35	6	16663	4	34	34

Interface residues

• A-B: ALA123A, ALA123B, ALA136A, ALA136B, ALA172A, ALA172B, ALA55A, ALA55B, ARG108A, ARG108B, ARG170A, ARG170B, ARG23A, ARG23B, ARG36A, ARG36B, ARG46A, ARG46B, ARG59A, ARG59B, ASN127A, ASN127B, ASN49A, ASN49B, ASP105A, ASP105B, ASP126B, ASP169A, ASP169B, ASP171A, ASP171B, ASP21A, ASP21B, ASP32A, ASP32B, ASP44A, ASP44B, CYS134A, CYS134B, CYS50A, CYS50B, CYS76A, CYS76B, GLN47A, GLN47B, GLU137A, GLU137B, GLU28A, GLU28B, GLY24A, GLY24B, GLY34A, GLY34B, GLY56A, GLY56B, GLY60A, GLY60B, GLY79A, GLY79B, HIS19A, HIS19B, HIS33A, HIS33B, HIS62A, HIS62B, ILE18A, ILE18B, LEU133A, LEU133B, LEU167A, LEU167B, LEU25A, LEU25B, LEU30A, LEU30B, LEU43A, LEU43B, LEU58A, LEU58B, MET131A, MET131B, PHE121A, PHE121B, PHE26A, PHE26B, PHE27A, PHE27B, PHE35A, PHE35B, PRO16A, PRO16B, SER128A, SER128B, SER166A, SER166B, SER168A, SER168B, SER22A, SER22B, SER42A, SER42B, SER51A, SER51B, SER53A, SER53B, SER54A, SER54B, SER78A, SER78B, THR110B, THR129A, THR129B, THR31A, THR31B, THR75A, THR75B, TRP29A, TRP29B, TYR132A, TYR132B, TYR138A, TYR138B, TYR73A, TYR73B, VAL130A, VAL130B, VAL20A, VAL20B, VAL45A, VAL45B, VAL48A, VAL48B, VAL52A, VAL52B, VAL57A, VAL57B, VAL77A, VAL77B